
A clear majority of people in Germany believe the government's measures against rising fuel prices are inadequate, with 80% of respondents surveyed saying not enough is being done, the ZDF's Politbarometer poll released on Friday showed.
Some 14% consider the measures appropriate while 3% say they go too far.
Many people are calling for a temporary cut in taxes and levies on petrol and diesel, the survey found. Some 73% support such a step while 25% oppose it. That's backed by a majority across most party supporters, with only Green party supporters showing a split picture.
On Thursday, the German parliament passed a package of measures to help cushion the higher energy costs. Petrol stations will only be allowed to raise prices once a day at noon (1100 GMT), though they could cut prices anytime.
The new rule could take effect before Easter, though it is unclear whether it will curb prices. The Federal Cartel Office is also to be given more powers to act against excessive prices.
LATEST POSTS
- 1
Banks for High Fixed Store Rates: Augment Your Investment funds - 2
Hundreds rally in West Bank against Israeli death penalty for Palestinians - 3
Taste the World: Five Food sources That Have Dazzled Worldwide Palates - 4
The Strait of Hormuz Isn’t Just an Oil Problem, It’s Now a Food Problem - 5
One-third of asylum applications by Iranians approved in Germany
We may have less control over how long we live than previously thought
Porsche May Kill the Electric Boxster Before It Ever Arrives
'Outrageous and illegal' : UNRWA slams Israel for cutting off its water, comms and electric in Gaza
Israel strikes Iranian nuclear development facilities, Tehran vows retaliation
Story of ‘first Black Briton’ rewritten by advances in ancient DNA technology
How HIV/AIDS got its name − the words Americans used for the crisis were steeped in science, stigma and religious language
Cameroon says Russia has confirmed 16 Cameroonian soldiers died in Ukraine
Vote In favor of Your Favored Web-based Venture Stage
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug












